Volume 10, Issue 3 (Autumn 2013)
Sci J Iran Blood Transfus Organ 2013, 10(3): 239-245 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Ghorbani Ali-Abadi E, Tavasooli A, Gharehbaghian A, Kasraian L, Khademi R, Taleie A. Evaluation of frequency and specificity of RBC alloantibodies in Namazi Hospital patients in Shiraz, 2010. Sci J Iran Blood Transfus Organ 2013; 10 (3) :239-245
URL: http://bloodjournal.ir/article-1-793-en.html
URL: http://bloodjournal.ir/article-1-793-en.html
Full-Text [PDF 198 kb]
(2402 Downloads)
| Abstract (HTML) (10583 Views)
Evaluation of frequency and specificity of RBC alloantibodies
in Namazi Hospital patients in Shiraz, 2010
Ghorbani Ali-Abadi E.1,2, Tavassoli A.R.1,2, Gharehbaghian A.3,4, Kasraian L.1,2,
Khademi R.1, Taleie A.1,2
1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
2Shiraz Regional Educational Blood Transfusion Center, Shiraz, Iran
3Paramedical Faculty, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4Pediatric Congenital Hematologic Disorders Research Center of Shahid Beheshti University of Medical Sciences,Tehran, Iran
Abstract
Background and Objectives
Alloimmunization with the prevalence rate of 60% is a common problem in chronically transfused patients. This problem has been reported to be less common in transfused hospital-based patients, amounting to 1-2 percent. Alloimmunization can lead to some difficulty varying from delay in the provision of similar blood types to delayed hemolytic transfusion reactions. The aim of this study was to analyze alloimmunization against RBCs among non-chronically transfused patients in Namazi Hospital in Shiraz.
Materials and Methods
Retrospective analysis of 3487 non-chronically transfused patients was conducted with antibody screening test and identification of patients' alloantibodies with the panel cell test. For patients with alloantibody, the data for sex, age, and history of transfusion and surgery were collected. Finally, the data were analyzed by SPSS software v. 15 using chi-square (CI= 95%).
Results
Twenty-eight out of 3487 patients had alloantibody (prevalence rate of 0.8%). The most common clinically significant alloantibodies found were anti-K (23%), anti- E (15%) and anti-C (11%). The most common clinically significant alloantibodies identified in males and females were anti-K and anti-C, respectively.
Conclusions
Alloantibody prevalence rate did not show any correlation with age and sex and was more common in patients with surgery history and transfusion record. Important factors contributing to the higher prevalence of the above alloantibodies are the higher prevalence of the related antigens in the population, higher antigenicity power, and the lack of crossmatch and grouping for the antigens before blood transfusion.
Key words: RBC antigens and antibodies, Serological testing, Blood Transfusion
Received: 10 Dec 2011
Accepted: 3 Mar 2013
Correspondence: Gharehbaghian A., PhD of Clinical Immunohematology. Associate Professor of Paramedical Faculty, Shahid Beheshti University of Medical Sciences and Pediatric Congenital Hematologic Disorders Research Center of Shahid Beheshti University of Medical Sciences.
P.O.Box: 19857-17443, Tehran, Iran. Tel: (+9821) 22439982; Fax: (+9821) 22439982
E-mail: Gharehbaghian@gmail.com
Full-Text: (1538 Views)
References:
- Pinkerton PH, Coovadia AS, Goldstein J. Frequency of delayed hemolytic transfusion reactions following antibody screening and immediate-spin crossmatching. Transfusion 1992; 32(9): 814-7.
- Issitt PD, Anstee DJ. Applied blood group serology. Durham,NC: Montgomery Scientific Publications; 1998: 873-905.
- Zumberg MS, Procter JL, Lottenberg R, Kitchens CS, Klein HG. Autoantibody formation in the alloimmunized red blood cell recipient: clinical and laboratory implications. Arch Intern Med 2001; 161(2): 285-90.
- Shulman IA, Maffei LM, Downes KA. North American pretransfusion testing practices, 2001-2004: results from the College of American Pathologists Interlaboratory Comparison Program survey data, 2001-2004. Arch Pathol Lab Med 2005; 129(8): 984-9.
- Schonewille H, Haak HL, van Zijl AM. Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases. Transfusion 1999; 39(7): 763-71.
- Redman M, Regan F, Contreras M. A prospective study of the incidence of red cell allo-immunisation following transfusion. Vox Sang 1996; 71(4): 216-20.
- Schonewille H, van de Watering LM, Brand A. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures? Transfusion 2006; 46(4): 630-5.
- Ameen R, Al-Eyaadi O, Al-Shemmari S, Chowdhury R, Al-Bashir A. Frequency of red blood cell alloantibody in Kuwaiti population. Med Princ Pract 2005; 14(4): 230-4.
- Moafi AR, Rahgozar S, Pourfathollah AA, Hariri MM.
- Gharehbaghian A, Khademi R, Amiri F, Lotfi G, Rahbari Bonab M. Frequency and specificity of red blood cell alloantibodies in general patients population with request for surgery in four selected hospitals in Tehran. Vox Sang 2010; 99(Supplement 1): 339-40.
- Brecher M. Technical Manual. 15th ed. Bethesda, MD: AABB; 2005. p. 423-52.
- Huh YO. Pretransfusion Testing of Red Blood Cells: Current Status. Current Issues in Transfusion Medicine 1994; 3(1). Available from: http:// www3. mdanderson. org/~citm/H-94-01.html.
- Wallis JP. Is it time to give up the crossmatch? J Clin Pathol 2000; 53(9): 673-5.
- Winters JL, Pineda AA, Gorden LD, Bryant SC, Melton LJ 3rd, Vamvakas EC, et al. RBC alloantibody specificity and antigen potency in Olmsted County, Minnesota. Transfusion 2001; 41(11): 1413-20.
|
Original Article
|
|
Sci J Iran Blood Transfus Organ 2013; 10(3): 239-245 |
Evaluation of frequency and specificity of RBC alloantibodies
in Namazi Hospital patients in Shiraz, 2010
Ghorbani Ali-Abadi E.1,2, Tavassoli A.R.1,2, Gharehbaghian A.3,4, Kasraian L.1,2,
Khademi R.1, Taleie A.1,2
1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran
2Shiraz Regional Educational Blood Transfusion Center, Shiraz, Iran
3Paramedical Faculty, Shahid Beheshti University of Medical Sciences, Tehran, Iran
4Pediatric Congenital Hematologic Disorders Research Center of Shahid Beheshti University of Medical Sciences,Tehran, Iran
Abstract
Background and Objectives
Alloimmunization with the prevalence rate of 60% is a common problem in chronically transfused patients. This problem has been reported to be less common in transfused hospital-based patients, amounting to 1-2 percent. Alloimmunization can lead to some difficulty varying from delay in the provision of similar blood types to delayed hemolytic transfusion reactions. The aim of this study was to analyze alloimmunization against RBCs among non-chronically transfused patients in Namazi Hospital in Shiraz.
Materials and Methods
Retrospective analysis of 3487 non-chronically transfused patients was conducted with antibody screening test and identification of patients' alloantibodies with the panel cell test. For patients with alloantibody, the data for sex, age, and history of transfusion and surgery were collected. Finally, the data were analyzed by SPSS software v. 15 using chi-square (CI= 95%).
Results
Twenty-eight out of 3487 patients had alloantibody (prevalence rate of 0.8%). The most common clinically significant alloantibodies found were anti-K (23%), anti- E (15%) and anti-C (11%). The most common clinically significant alloantibodies identified in males and females were anti-K and anti-C, respectively.
Conclusions
Alloantibody prevalence rate did not show any correlation with age and sex and was more common in patients with surgery history and transfusion record. Important factors contributing to the higher prevalence of the above alloantibodies are the higher prevalence of the related antigens in the population, higher antigenicity power, and the lack of crossmatch and grouping for the antigens before blood transfusion.
Key words: RBC antigens and antibodies, Serological testing, Blood Transfusion
Received: 10 Dec 2011
Accepted: 3 Mar 2013
Correspondence: Gharehbaghian A., PhD of Clinical Immunohematology. Associate Professor of Paramedical Faculty, Shahid Beheshti University of Medical Sciences and Pediatric Congenital Hematologic Disorders Research Center of Shahid Beheshti University of Medical Sciences.
P.O.Box: 19857-17443, Tehran, Iran. Tel: (+9821) 22439982; Fax: (+9821) 22439982
E-mail: Gharehbaghian@gmail.com
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
